The MYO15A gene gives instructions for a protein that helps build and maintain the tiny inner ear structures that detect sound. This gene plays an important role in helping these cells turn sound vibrations into signals the brain can use. If it does not work properly, those structures may not form as expected, which can lead to hearing loss, often from birth or early childhood. Pathogenic variants in the MYO15A gene are a well established cause of inherited hearing loss that usually affects hearing without causing a broader health condition.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the working parts of cells. Other genes mostly help determine when, where, and how strongly certain processes occur. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can find more in the LearnHub.
Overview
MYO15AGene function
What if the gene works
The MYO15A gene helps cells in the inner ear build and maintain the tiny hairlike structures needed for hearing. Its protein supports their length and organization, helping sound signals reach the brain clearly.
Risk
What if the gene does not work
Variants in the MYO15A gene usually cause inherited sensorineural hearing loss from birth or early childhood. Milder to more severe variants can influence how much hearing is affected and whether some hearing remains.
Treatment
What does that mean for your treatment
No MYO15A-specific treatment or management approach is currently established. Care is guided by hearing needs, and no drug choice is currently directed by a pathogenic variant in the MYO15A gene.
Conditions associated with MYO15A
Gene function
What if the gene works
In the inner ear, the MYO15A gene helps tiny sound sensing cells do their work each day. It supports the growth and upkeep of fine hair like projections that pick up vibration, a key part of how the inner ear supports hearing.
The MYO15A gene helps inner ear cells build the long hair like projections that detect sound. Its protein gathers at the tips, where careful growth is directed.
These projections work best when they form a neat staircase pattern. The MYO15A gene helps keep that structure organized so vibrations are picked up in a controlled way.
Inside sound sensing cells, the MYO15A gene helps move key helper proteins to the right spot. This supports the tip area, where the projections are built and renewed.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not lead to any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or directly cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the MYO15A gene change the shape of the myosin XVA protein or shorten it, so it may not work properly or reach the right place in inner ear cells. More disruptive variants can leave little or no working protein, while milder variants may preserve some activity. This helps explain why hearing loss linked to MYO15A gene variants can vary, including when hearing changes begin and how marked they are.
How variants are linked to conditions
Variants in the MYO15A gene are a well-established cause of inherited nonsyndromic hearing loss, most often autosomal recessive DFNB3. Many people with pathogenic variants in both copies are born with hearing loss or develop it in early childhood, usually in both ears. MYO15A gene variants linked to hearing loss are often associated with severe to profound hearing loss, though some are tied to milder or later-onset patterns.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some cases, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Risk of hearing loss linked to MYO15A is mainly set by genetics: a child is affected when they inherit harmful variants in both copies, usually one from each parent. Family history and both parents carrying a MYO15A variant raise the chance. There is not enough evidence that lifestyle changes alter this genetic risk.
Inheritance of MYO15A variants
MYO15A-related hearing loss is usually inherited in an autosomal recessive pattern, which is the key point in understanding how MYO15A gene variants are inherited. This means a child typically inherits one MYO15A variant from each parent, and the parents are often healthy carriers. When both parents carry a disease-causing variant in the MYO15A gene, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a carrier child, and a 25% chance of resulting in a child without either variant.
What does my MYO15A result mean for my family?
MYO15A results are most often linked to an inherited form of hearing loss that runs in families in a recessive way. For relatives, this usually means brothers and sisters may also have hearing loss or be carriers, and parents are often carriers even if they hear normally. Other close family members may also be carriers, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for MYO15A variants usually uses a blood or saliva sample to read the MYO15A gene and look for changes linked to inherited hearing loss. It is often part of a hearing loss gene panel or broader DNA sequencing test, and results may identify a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the MYO15A gene may be worth considering if someone has hearing loss that started at birth or in early childhood, especially if it is severe or runs in the family. It can help explain the cause and clarify whether other relatives or future children could also be affected.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they reveal depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may break down, move, or respond to a drug in different ways. This is common and can influence how well a medicine works or how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies gene drug relationships to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the MYO15A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. Questions about treatment, side effects, or changes in your health are best discussed with your doctor, who can look at the full picture.
History
Interest in the MYO15A gene grew as researchers worked to explain inherited hearing loss in families where several relatives were affected from birth or early childhood. In the late 1990s, scientists linked changes in this gene to a form of autosomal recessive nonsyndromic hearing loss called DFNB3. This was an important step because it helped connect a clearly inherited pattern of deafness to a specific gene. From these first observations, research expanded steadily, and MYO15A became recognized as one of several genes involved in hearing. Studies in families from different parts of the world later showed that variants in the MYO15A gene can appear in many populations. These findings helped shape modern genetic testing for inherited hearing loss.